Portfolio company
Acerta Pharma
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This biopharmaceutical company develops covalent binding medicines for patients with blood cancers and autoimmune diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Pharmacyclics
This company develops small-molecule medicines for patients with cancer and immune-mediated diseases.
Biopharmaceutical company
This firm develops small molecule drugs targeting protein regulatory sites to treat patients with cancer and autoimmune diseases.
BlossomHill Therapeutics
This biopharmaceutical company develops small molecule medicines to treat patients with various forms of cancer and autoimmune disorders.
Matchpoint Therapeutics
This biotechnology company develops oral covalent small molecule medicines to treat patients with autoimmune and inflammatory diseases.
ArgenX
This company develops and commercialises antibody-based therapies to treat patients suffering from severe autoimmune diseases and cancer.
Enlaza Therapeutics
This biotechnology company develops covalent protein medicines that form irreversible bonds with disease targets to treat patients with cancer and autoimmune conditions.
Principia Biopharma
The company develops oral small molecule therapies for patients with immune-mediated diseases and cancer.
LTZ Therapeutics
This biopharma company develops myeloid engager immunotherapies for patients with cancer and autoimmune diseases.
